The C360 planning methodology has evolved over decades of clinical marketing experience. Scott Mader initiated the evidence based process while launching blockbuster pharmaceutical brands, then moved west where he continued to refine the process & demonstrate its value for small biotechnology companies as he led the commercial success of Biosite Diagnostics.  In 2003 Scott launched C360 consulting focused on delivering client success in the clinical marketplace.  Contact us to find out how C360 can bring excellence in strategic planning to your biopharmaceutical or biotechnology brands.